Form POSASR Mersana Therapeutics,

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Form POSASR Mersana Therapeutics,

BTIG Upgrades Mersana (MRSN) to Buy

February 28, 2024 3:38 PM EST

BTIG analyst Kaveri Pohlman upgraded Mersana (NASDAQ: MRSN) from Neutral to Buy with a price target of $6.00.

The analyst comments "We believe that the upcoming catalysts this year could significantly de-risk the Dolasynthen platform and the lead ADC, XMT-1660 (B7-H4 Dolalock ADC),... More